Physiology · Year 1 · from Physiology
Case 2: Botulism - Presynaptic Release Failure
Clinical Image
Source: Wikimedia Commons - Botulinum toxin structure - Public Domain
Patient Presentation
A 28-year-old male presents to the emergency department with progressive weakness, blurred vision, difficulty swallowing, and dry mouth over the past 18 hours. He attended a home-canning demonstration 36 hours ago where he ate home-preserved green beans and meat. Two other attendees have been hospitalized with similar symptoms. He denies fever, sensory changes, or confusion.
Demographics
- Age: 28 years
- Sex: Male
- Exposure: Home-canned vegetables (green beans) 36 hours prior
Chief Complaint
Progressive descending weakness, diplopia, dysphagia, and dry mouth
Physical Examination
- Vital signs: BP 118/76, HR 92, RR 20, Temp 37.0C, SpO2 94% on room air
- General: Alert but anxious, weak voice
- Cranial nerves:
- Pupils: Dilated bilaterally, sluggish light response
- Ptosis: Bilateral
- Eye movements: Ophthalmoplegia (limited movement in all directions)
- Facial weakness: Bilateral, symmetric
- Bulbar weakness: Absent gag reflex, weak tongue movements
- Motor: Symmetric weakness, worse proximally (4/5 upper, 4/5 lower), descending pattern
- Reflexes: Diminished 1+ throughout
- Sensory: Intact
- Autonomic: Dry mouth, constipation reported
Workup
- Mouse bioassay: Positive for botulinum toxin type A (gold standard, but takes days)
- Stool culture: Clostridium botulinum isolated
- Food sample analysis: Pending (from green beans)
- Repetitive nerve stimulation: Incremental response at high-frequency stimulation (20-50 Hz) - characteristic of presynaptic NMJ disorder
- EMG: Small amplitude, brief motor unit potentials with facilitation after exercise
- Lumbar puncture: Normal (helps exclude GBS)
- CT/MRI brain: Normal
Diagnosis
Foodborne Botulism (Clostridium botulinum toxin type A)
Treatment
- Immediate ICU admission for airway monitoring
- Intubation and mechanical ventilation (likely required for weeks)
- Trivalent botulinum antitoxin (equine-derived) as soon as possible - does not reverse existing paralysis but prevents progression
- Supportive care: Nutrition (NG tube or PEG), DVT prophylaxis, prevention of secondary infections
- Public health notification and investigation of food source
- Contact tracing for other exposed individuals
- No antibiotics for foodborne botulism (may increase toxin release)
- Rehabilitation during prolonged recovery (weeks to months)
Physiological Principles Demonstrated
- SNARE-mediated vesicle fusion: Neurotransmitter release requires SNARE proteins (synaptobrevin/VAMP on vesicles; syntaxin and SNAP-25 on presynaptic membrane) to form a complex that pulls membranes together for fusion.
- Botulinum toxin mechanism: Botulinum toxin is a zinc-dependent protease that cleaves specific SNARE proteins, preventing vesicle fusion and blocking ACh release. Different serotypes cleave different targets: Type A cleaves SNAP-25; Types B, D, F, G cleave synaptobrevin.
- Presynaptic vs. postsynaptic disorders: Unlike myasthenia gravis (postsynaptic), botulism affects the presynaptic terminal. EMG shows facilitation with rapid stimulation (calcium accumulation partially overcomes the block) and incremental response to RNS.
- Descending paralysis pattern: The toxin preferentially affects cranial nerves first, then descends to respiratory and limb muscles, opposite to the ascending pattern in GBS.
- Autonomic involvement: Cholinergic parasympathetic neurons are also affected, causing dilated pupils, dry mouth, constipation, and urinary retention - features that help distinguish botulism from MG.
- Recovery mechanism: New nerve terminals must sprout and form new synapses, explaining the prolonged recovery over weeks to months.